What is STKE's health score?

SOL Strategies Inc. (STKE) has a TradeApes health score of 46 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is STKE's estimated fair value?

Based on our 5-year discounted cash flow model, SOL Strategies Inc.'s estimated fair value is $2.12 per share, representing a 86.3% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is STKE undervalued or overvalued?

Our model currently rates STKE as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

3 free score cards remaining

SOL Strategies Inc. (STKE)

Financials Undervalued low mixed

$1.14

Updated: 2026-07-16

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

40 Weak

Relative Value

60 Healthy

Capital Allocation

30 Weak

Risk Management

50 Mixed

Est. Fair Value $2.12

DCF Upside +86.3%

Sector Rank #1614 of 12160

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees

Unlock Full Report →

Industry Related Stocks

Athena Bitcoin Global (ABIT) American Bitcoin Corp. (ABTC) Abits Group Inc (ABTS) AIxCrypto Holdings, Inc. (AIXC) Amber International Holding Ltd (AMBR) AMTD IDEA GROUP (AMTD)

See all Financials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.